BioCardia Inc. Common Stock

REPLAY BUTTONS

∣‹ ‹‹ ∥ › ›› ›∣

POSITION	OPEN	PROFIT	P & L
LONG
SHORT

BioCardia Inc. Common Stock. Replay the stock market charts of BCDA day by day back to 2003. Open long and short positions without spending any money. Unknown

BCDA Daily Chart

BCDA Options Chain

BioCardia's CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
May 1, 2024
BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
March 13, 2024
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
March 12, 2024
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study - BioCardia ( NASDAQ:BCDA )
March 12, 2024
BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure - BioCardia ( NASDAQ:BCDA )
March 4, 2024
Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight
January 15, 2024
BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders - BioCardia ( NASDAQ:BCDA )
January 3, 2024
BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection Fraction
December 19, 2023
BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes
December 18, 2023
BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product Approval
November 29, 2023

BCDA Free Cash Flow

BCDA Income Statement

BCDA Stock Price vs Net Income

BCDA Financial Reports